MoCA — Montreal Cognitive Assessment
30-point cognitive screening tool more sensitive than MMSE for mild cognitive impairment (MCI). Assesses 8 cognitive domains.
How to use & interpret
The Montreal Cognitive Assessment (MoCA) is a 30-point screen that is more sensitive than the MMSE for mild cognitive impairment, testing executive function, attention, memory, language, visuospatial skills and orientation. A score of ≥26 is generally considered normal, and one point is added for people with 12 or fewer years of education.
It is a screening and monitoring tool, interpreted alongside history, functional impact and, where needed, further investigation — not a stand-alone diagnosis.
Score interpretation
Score ≤17. Significant cognitive impairment — consistent with dementia.
→ Urgent geriatric/memory clinic referral. Capacity assessment. Consider reversible causes (thyroid, B12, depression). Imaging.
Score 18–25 suggests MCI or early dementia.
→ Memory clinic referral. Screen for reversible causes. Reassess in 6–12 months. Driving assessment if applicable.
Score ≥26 (with education adjustment) — within normal range.
→ No cognitive impairment detected. Reassess if symptoms persist or worsen.
Interpretation bands for the MoCA. Apply clinical judgement and local guidance.
Frequently asked questions
MoCA or MMSE?
MoCA is more sensitive for mild cognitive impairment and executive dysfunction; MMSE is quicker and more familiar. MoCA is often preferred when early or subtle impairment is suspected.
References
- Nasreddine ZS et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
Related
Curated clinical cross-links plus same-class fallbacks.
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Mini-Mental State Examination (MMSE) · Cognitive Assessment
- Mini-Mental State Examination (MMSE) · Cognitive Assessment
- 6-Item Cognitive Impairment Test (6CIT) · Cognitive Assessment
- 6CIT — 6-Item Cognitive Impairment Test · Cognitive Assessment
- Abbreviated Mental Test Score (AMT-10) · Cognitive Assessment
- Donepezil · Acetylcholinesterase inhibitor (AChEI) — dementia
- Memantine · NMDA receptor antagonist — dementia
- Rivastigmine · Dual AChEI and BuChEI inhibitor — dementia
- Quetiapine (Elderly — Dementia Caution) · Atypical Antipsychotic
- Memantine · NMDA Receptor Antagonist — Dementia
- Rivastigmine · Acetylcholinesterase Inhibitor — Dementia
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.